Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Sigma-Tau plans phase II European trial of TB4 for venous stasis ulcers

June 29, 2004

Liarozole receives U.S. orphan drug status for congenital ichthyosis

June 25, 2004

FDA sets action date for Metvix review

June 21, 2004

Novel IL-8 receptor antagonists and their use described by GSK

June 18, 2004

Synthetic Australian snake venom derivative effective for wound healing

June 17, 2004

Human serpin with potential to heal diabetic ulcers

June 16, 2004

Bradley Pharmaceuticals to acquire Bioglan

June 15, 2004

Cytomodulin promotes collagen transcription and wound healing in mice

June 14, 2004

New glucocorticosteroids prepared and tested at GSK

June 11, 2004

Orphan drug designation for Thymosin beta4 for epidermolysis bullosa

June 11, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Asia
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
4D Nucleome opens new wave of gene regulation research, discovery
BioWorld
After a decade of research, the NIH 4D Nucleome program on July 23 delivered a wealth of new insights into how spatial changes in chromatin structure and DNA...
Capital remains selective in ‘barbell’ biotech market
BioWorld Asia
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Other news to note for July 22, 2026
BioWorld
Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Akari, Ashlins, Azurity, Eli Lilly, Engitix, Forge Biologics,...